Project Grant K12TR005442
- The National Center for Advancing Translational Sciences awarded a cooperative agreement to Georgetown University for $3.969 million on August 4, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). Georgetown University leads the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a multi-institutional partnership that includes Howard University, MedStar Health Research Institute, the Washington DC Veterans...
- The National Center for Advancing Translational Sciences awarded University of Massachusetts Medical School $949,994 on April 1, 2026, under the NCATS program (CFDA 93.350) to support a K12 career development program in translational science. The award funds the development and mentorship of junior faculty scholars pursuing careers in translational science. The program will support four NCATS-funded scholars at any given time, forming the core of a nine-scholar umbrella initiative that...
- The National Center for Advancing Translational Sciences awarded Georgetown University $752,548 on September 1, 2026, under the CTSA K12 Program (CFDA 93.350) to support clinical and translational science training and career development for early-stage investigators. Georgetown University operates the K12 program as part of the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a partnership that includes Howard University, MedStar Health Research...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded Georgetown University $206,908 on September 1, 2026, under the CTSA Postdoctoral T32 Program (CFDA 93.350) to support a two-year translational biomedical science training program for postdoctoral fellows. Georgetown University leads the Georgetown-Howard Universities Center for Clinical and Translational Sciences (GHUCCTS), a multi-institutional partnership also comprising Howard University,...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded a cooperative agreement to New York University on March 20, 2026, obligating $38.325 million under CFDA 93.350 (National Center for Advancing Translational Sciences). The award funds the New York University Clinical and Translational Science Institute (CTSI) hub, which will enhance community-engaged research, democratize health informatics resources, develop a well-rounded translational...
- The National Center for Advancing Translational Sciences awarded the University of California Irvine $1.512 million on March 15, 2026, under the NCATS K12 Project Grant program (CFDA 93.350) to establish a mentored career development core for clinical translational science and research. The program supports the training of four K12 scholars per year through structured mentorship, individual development planning, and scholar-mentor alignment oversight. UCI operates an affiliated scholars...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded Georgetown University $181,747 on August 7, 2026, under the NCATS program (CFDA 93.350) to support a predoctoral training program in translational biomedical science. Georgetown University, in partnership with Howard University, MedStar Health Research Institute, the Washington DC Veterans Administration Medical Center, and Oak Ridge National Laboratory, operates the Georgetown-Howard...
- The National Center for Advancing Translational Sciences awarded the University of Massachusetts Medical School $328,040 on August 15, 2026, under the CTSA Predoctoral T32 training program (Assistance Listing 93.350) to develop a two-year predoctoral training program in clinical and translational science. The program will recruit three cohorts of six doctoral students with guaranteed funding across rigorous doctoral programs in nursing, MD/PhD, population health sciences, epidemiology,...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $156,000 project grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded September 1, 2025, with completion scheduled for August 31, 2027. This award supports a clinical research project investigating the effects of earlier and higher vitamin D supplementation in extremely premature newborns, with primary outcome assessments at two years of age. The...
- The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) at the National Institutes of Health awarded a cooperative agreement totaling $5.801 million to the Trustees of Boston University (Boston University Medical Campus) on August 22, 2026, to establish and operate the Boston University Clinical and Translational Science Institute (BU CTSI) Hub. The BU CTSI Hub delivers translational science infrastructure and research acceleration services spanning regenerative medicine,...
The National Center for Advancing Translational Sciences awarded the University of Texas Medical Branch at Galveston $711,020 on September 1, 2026, under the NCATS program (CFDA 93.350) to establish and operate the Greater Gulf Coast Translational Science Alliance (GGCTSA) K12 Scholars Program. The program delivers career development training in translational science skills and principles to early-career research faculty through cooperative mentoring by an alliance of four Houston-area institutions: UTMB (prime recipient), Houston Methodist, Texas Southern University, and the University of Houston-Clear Lake. UTMB's CTSA has operated a scholars program since 2009, producing independent translational researchers through multidisciplinary mentoring focused on leadership, entrepreneurship, and community engagement. The expanded alliance leverages Houston Methodist's clinical trials network and translational research facilities, Texas Southern University's pharmacy and pharmaceutical sciences programs and community outreach, and the University of Houston-Clear Lake's teacher training, mental healthcare, and social science programs to expand the hub's reach into new translational science career pathways and strengthen the translational workforce across the Houston-Galveston region. The award period runs through May 31, 2031, with place of performance in Galveston, Texas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $711.0k | 8/24/26 |